Posted on 9/24/19
Here's Why BioCryst Pharmaceuticals Popped Today
What happenedShares of BioCryst Pharmaceuticals (NASDAQ:BCRX), a clinical-stage biotech focused on treating rare diseases, popped after the company announced the appointment of a new board member. . . .
Posted on 9/22/19
ARS Treatment Centers Announces Two New Office-Based Opioid Treatment Clinics in New Jersey
NEWARK, N.J. & GREENVILLE, S.C.--(BUSINESS WIRE)--ARS Treatment Centers, a national leader in Office-Based Opioid Treatment (OBOT), announced today that it is continuing its expansion in New . . .
Posted on 9/19/19
PPD Expanding Bioanalytical Laboratory Capabilities
WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD), is expanding its bioanalytical laboratory in Richmond, Virginia, enhancing its ability to provide industry-leading capabilities to meet biopharmaceutical clients’ . . .
Posted on 9/18/19
IQVIA Collaborates with Cancer Researchers
DANBURY, Conn. & RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV) is proud to announce its collaboration with Friends of Cancer Research in a cross-industry effort to advance . . .
Posted on 9/12/19
Premier Boosts Projections for FY2020 Drug Costs
Premier Inc. expects pharmaceutical prices to rise 4.2 percent in fiscal 2020, up from the 3.8 percent inflation the company predicted in February.The company said most . . .
Posted on 9/11/19
Dance Biopharm Partners With DarioHealth
Dance Biopharm Holdings, Inc., a clinical-stage company reimagining the treatment of chronic diseases with inhaled therapies, announced today it has formed a strategic alliance with DarioHealth . . .
Posted on 9/9/19
PRA Health Sciences Prices Secondary Offering
PRA Health Sciences said that a secondary offering by KKR PRA would be priced at $97.50 per share.PRA holder KKR PRA Investors announced plans to offer . . .
Posted on 9/9/19
PRA Health Sciences Announces $500M Buyback Program
PRA Health Sciences Inc. has authorized a $500 million share repurchase program, the company announced Tuesday.Effective immediately, the repurchase program means that the company can buy . . .
Posted on 8/25/19
Tenax Therapeutics Accelerates Enrollment in Levosimendan Study
Tenax Therapeutics Inc., a specialty pharmaceutical company focused on cardiovascular and pulmonary diseases, is accelerating enrollment in a Phase 2 trial.The company now expects full enrollment . . .
Posted on 8/21/19
Aeterna Zentaris Announces Director Change
CHARLESTON, S.C., Aug. 20, 2019 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) today announced that Jonathan Pollack has resigned as a director of . . .
Posted on 8/11/19
Fennec Provides Business Update
RESEARCH TRIANGLE PARK, N.C., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company focused on the development of PEDMARK™ . . .
Posted on 8/6/19
Dova Pharmaceuticals Reports Second Quarter 2019 Operating and Financial Results
DURHAM, N.C., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (Nasdaq: DOVA), a pharmaceutical company focused on acquiring, developing, and commercializing drug candidates for diseases . . .
Posted on 8/5/19
Blue Wolf Capital Acquires RHA Health Services
Today, Blue Wolf Capital Partners, a New York-based private equity firm, announced the acquisition of RHA Health Services (RHA), a leading provider of community-based health
Posted on 8/5/19
2019’s Best & Worst States for Health Care – WalletHub Study
According to the CDC, 87.6 percent of the population has a regular place to go for medical care. But the cost and service quality of that . . .
Posted on 8/1/19
Progknowse Announces Partnerships with Three Health Systems
CHARLOTTE, N.C. & TYSONS, Va.--(BUSINESS WIRE)--Progknowse Inc., a precision medicine technology company seeking to produce predictive analytics with state-of-the-art algorithms using machine learning, has announced partnerships . . .
Posted on 7/22/19
Closing NC's Healthcare Gap Gives State Economic Boom & 400K Residents Affordable Healthcare Options
Healthcare, business, and community leaders, and members of the media met in Pinehurst, NC on Friday to discuss the economic and health impact of the Healthcare . . .
Posted on 7/18/19
Durham's Precision Biosciences Opens First U.S. CAR T Cell Therapy Manufacturing Facility
Research Triangle Park Facility to Manufacture Precision’s Pipeline of Off-the-Shelf CAR T Product Candidates to Support Clinical TrialsPrecision BioSciences, Inc. (Nasdaq: DTIL), a genome editing company . . .
Posted on 7/17/19
Dova Pharmaceuticals: Analysis Of Doptelet's Potential In Various Thrombocytopenias
SummaryThe company’s lead product is Doptelet (avatrombopag), an oral, thrombopoietin receptor agonist, which received FDA approval for treating refractory chronic idiopathic thrombocytopenia in adults.Doptelet is also . . .
Posted on 7/15/19
Boston Children’s Hospital Forms Strategic Partnership with Premier
CHARLOTTE, N.C.--(BUSINESS WIRE)--Boston Children’s Hospital, one of the largest pediatric medical centers in the U.S., has partnered with Premier Inc. (NASDAQ: PINC), a leading healthcare improvement . . .
Posted on 6/25/19
AdhereHealth And Papa Partner to Tackle Barriers of Care
AdhereHealth™, a leading healthcare technology company focused on medication adherence, has announced a partnership with Papa, an award-winning companionship platform company serving the elderly, blind and . . .
Posted on 6/20/19
SERAXIS inks Research Collaborative Agreement with North Carolina Research Hospital
SERAXIS Inc., the developer of SR-01, a cell therapy for insulin-dependent diabetes, today announces signing a research collaboration agreement with Wake Forest Baptist Health to further . . .
Posted on 6/19/19
Novan Expands External Business Partner Network
MORRISVILLE, N.C., June 19, 2019 (GLOBE NEWSWIRE) -- Novan, Inc. (Nasdaq:NOVN) today announced continued business advancements in both formulation science and manufacturing. These advancements are consistent . . .
Posted on 6/18/19
Health Decisions and DSP Clinical Research Form Strategic Partnership
Health Decisions, Inc., a full-service contract research organization (CRO) specializing in women's health clinical research and diagnostic development, today announced the formation of a strategic partnership . . .
Posted on 6/18/19
Premier Partners with Pensiamo Inc. and UPMC
PITTSBURGH & CHARLOTTE, N.C.--(BUSINESS WIRE)--Premier Inc. (NASDAQ: PINC), a healthcare improvement company, and Pensiamo Inc., a cognitive supply chain company, have partnered to launch a new . . .
Posted on 6/4/19
BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
RESEARCH TRIANGLE PARK, N.C., June 04, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc.(Nasdaq:BCRX) today announced that the compensation committee of BioCryst’s board of directors granted four . . .
Charlotte Raleigh
